Plain-English translation of NCT05951660 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Sexual dysfunction is a common and distressing side effect of schizophrenia medications and is also linked to diabetes—but doctors and patients rarely talk about it. This study tests whether targeted education helps doctors and patients recognize, discuss, and manage these side effects better. You'll be placed into one of four groups: some patients receive education, some healthcare providers receive education, some get both, and some serve as a comparison group.
Many people with schizophrenia experience sexual problems from their medications, which can make them stop taking treatment and feel worse overall. However, these side effects are hardly ever discussed in routine clinical care. This trial wants to see if teaching patients and doctors about this problem helps them address it more openly and effectively.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive education about sexual side effects (as a patient, as part of your healthcare team, or both), or to a group that doesn't receive the education. The study will track how many times doctors systematically ask about sexual side effects, whether treatment changes happen, and whether you notice improvements in how severe these side effects feel. You'll likely complete questionnaires and have follow-up visits at one of 16 participating community mental health centers across Denmark.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Denmark